A bacteriophage journey at the European Medicines Agency

The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy.

Detalles Bibliográficos
Autores principales: Debarbieux, Laurent, Pirnay, Jean-Paul, Verbeken, Gilbert, De Vos, Daniel, Merabishvili, Maia, Huys, Isabelle, Patey, Olivier, Schoonjans, Dirk, Vaneechoutte, Mario, Zizi, Martin, Rohde, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812529/
https://www.ncbi.nlm.nih.gov/pubmed/26656541
http://dx.doi.org/10.1093/femsle/fnv225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812529/
https://www.ncbi.nlm.nih.gov/pubmed/26656541
http://dx.doi.org/10.1093/femsle/fnv225

Ejemplares similares